Diagnostic Evaluation of Pre‑Surgical Hypoglycemia in Bariatric Surgery Candidates
Timing and Pattern of Hypoglycemia
- Fasting hypoglycemia that occurs soon after bariatric surgery is more likely attributable to a pre‑existing insulinoma rather than post‑gastric‑bypass nesidioblastosis. 1
- Post‑bariatric nesidioblastosis typically develops many months after the operation and presents predominantly in the post‑prandial period, not during fasting. 2
Biochemical Workup
- During a documented hypoglycemic episode, obtain plasma glucose, insulin, C‑peptide, proinsulin, and β‑hydroxybutyrate to differentiate endogenous hyperinsulinism from other mechanisms. 3
- Screen for oral hypoglycemic agents—including all sulfonylureas and glinides—to exclude drug‑induced hypoglycemia. 2
- Test for insulin antibodies to identify autoimmune hypoglycemia. 3
- Perform a glucagon stimulation test (1 mg IV) with measurement of the plasma glucose response as part of the evaluation. 3
Diagnostic Thresholds for Endogenous Hyperinsulinism
- Confirm endogenous hyperinsulinism when plasma glucose is <55 mg/dL (3.0 mmol/L) in the presence of symptoms. 3
- Insulin level ≥3.0 μU/mL (18 pmol/L) supports the diagnosis. 3
- C‑peptide level ≥0.6 ng/mL (0.2 nmol/L) is diagnostic. 3
- Proinsulin level ≥5.0 pmol/L meets the criterion. 3
- β‑hydroxybutyrate level ≤2.7 mmol/L is consistent with endogenous hyperinsulinism. 3
- An increase in plasma glucose of ≥25 mg/dL (1.4 mmol/L) after IV glucagon fulfills the stimulation criterion. 3
Imaging Localization of Insulinoma
- Contrast‑enhanced CT or MRI detects 70–85 % of insulinomas and should be the first imaging modality. 5
- Endoscopic pancreatic ultrasonography with fine‑needle aspiration offers >90 % sensitivity at experienced centers and is valuable for lesion localization. 5
- Selective pancreatic arterial calcium stimulation with hepatic venous insulin sampling is recommended when non‑invasive imaging is equivocal or negative. 5